Results 131 to 140 of about 56,246 (208)

Obinutuzumab, lenalidomide, and venetoclax for the initial treatment of patients with advanced-stage follicular lymphoma: Results of the Phase Ib/II LEVERAGE study. [PDF]

open access: yesHemasphere
Cheah CY   +11 more
europepmc   +1 more source

CD20 Loss as a Mechanism of Resistance to Mosunetuzumab in Relapsed Follicular Lymphoma. [PDF]

open access: yesMediterr J Hematol Infect Dis
Canichella M   +4 more
europepmc   +1 more source

Chemotherapy-Sparing Strategies in Follicular Lymphoma: Emerging Targeted and Immune-Based Approaches. [PDF]

open access: yesEur J Haematol
Martino EA   +12 more
europepmc   +1 more source

Fixed-Duration Subcutaneous Mosunetuzumab in Relapsed/Refractory Follicular Lymphoma: Pivotal Phase 2 Primary Analysis. [PDF]

open access: yesAm J Hematol
Bartlett NL   +20 more
europepmc   +1 more source

Histological and Immunohistochemical Characterization of a Histiocytic Sarcoma Associated With a Follicular Lymphoma in a Ring-tailed Lemur (Lemur catta). [PDF]

open access: yesVet Med Sci
Aradilla N   +7 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy